中山肛列出血怎么办中山便血医生,中山华都肛肠医院评价如何,中山女性肛裂的治疗办法,中山便秘什么 原因,中山在线咨询痔疮,中山大便大量出血怎么回事,中山哪里治疗肛瘘比较好

SAN DIEGO (KGTV) -- Police are investigating after a man was stabbed in East Village Wednesday night. According to San Diego Police, the stabbing happened on the 1500 block of Commercial just after 5 p.m. Police say a 26-year-old man was involved in a fist fight with the suspect when, during the fight, the suspect stabbed the victim in the ribs. The 26-year-old was taken to the hospital with non-life threatening injuries. The suspect fled the scene and hasn’t been located, police say. He is described as a 35-year-old black man approximately five feet, seven inches tall and clean shaven. He was last seen wearing a light-colored, short-sleeved shirt and had a scar down his abdomen. 698

(CNN) -- Defense Secretary Mark Esper and Joint Chiefs Chairman Gen. Mark Milley have raised serious concerns with the White House in the last 48 hours after President Donald Trump signaled he would block the Navy from ejecting Eddie Gallagher from the SEALs, an administration official told CNN."There is extreme concern over decision making being pulled from the Navy," one administration official told CNN Saturday in reaction to Trump's Thursday tweet that "the Navy will NOT be taking away Warfighter and Navy Seal Eddie Gallagher's Trident Pin." The Trident Pin, which is worn by Navy SEALs, is awarded following their completion of an intense qualification course and symbolizes membership in the elite military community.As of Saturday afternoon, a review of Gallagher's status was expected to proceed. That review is considering whether he should be able to continue as a SEAL or be expelled, according to one defense official.RELATED: Navy to review Chief Edward Gallagher's fitness to serve, New York Times reportsTrump early this month ignored advice from the Pentagon and intervened in three war crimes cases. Trump pardoned two service members and restored Gallagher's rank.Gallagher had been demoted after being found guilty of posing for a photo with the dead body of an ISIS casualty in Iraq. He had faced a court-martial for premeditated murder and attempted murder, but was acquitted.On Thursday, the President tweeted that he wouldn't let the Navy punish Gallagher.Navy Secretary Richard Spencer on Saturday denied a New York Times report that he had threatened to resign or be fired if the President stopped the military from removing Gallagher from the elite group. Spencer was asked to respond to the Times report during a session at the Halifax International Security Forum in Nova Scotia, Canada.Spencer joked that he was there to talk about the Arctic, prompting laughter from the crowd, then denied the New York Times report outright, saying, "Contrary to popular belief, I am still here. I did not threaten to resign."RELATED: Trump says Navy won’t remove Gallagher’s SEAL’s designation"We're here to talk about external threats, and Eddie Gallagher is not one of them," Spencer said.The New York Times also reported that Rear Adm. Collin Green had made threats to resign or be fired.The official told CNN Saturday that the Pentagon is strongly urging the White House to let military discipline measures run their course without interference, meaning that military officials want to be able to make the decision about Gallagher's fate without the President weighing in.However, military officials acknowledge the President has the right as commander in chief to issue orders on military justice matters.A Navy official told CNN Friday that following Trump's tweet, the Navy had paused proceedings against Gallagher until additional guidance was provided by the White House.RELATED: Trump restores rank of San Diego Navy SEAL following war crimes caseSpencer said Friday the military review should proceed despite Trump's tweet, telling Reuters: "I believe the process matters for good order and discipline." Earlier Saturday, Chief Navy spokesman Rear Adm. Charles Brown told CNN that those comments from Spencer "are in line with current White House guidance."A spokesperson for Spencer told CNN that his comments were in line with previous statements the secretary has made about supporting his commanders.Gallagher's lawyer, Timothy Parlatore, has said that the Navy's decision to order the review of Gallagher's status was part of an effort to push back against Trump's earlier decision to restore the SEAL's rank. Parlatore has slammed the Navy's leadership, particularly Green who had ordered the review board.Green ordering the review "crossed a very dangerous line, having our uniformed flag officers being directly defiant of our commander in chief," Parlatore told CNN Thursday.Before the President acted earlier this month, Esper and other senior military leaders had warned Trump that his intervention could damage the integrity of the military judicial system, the ability of military leaders to ensure good order and discipline and the confidence of US allies and partners who host US troops. 4242

"Strong leads" are being pursued to catch two men believed to be responsible for multiple fatal shootings across the Nashville area, police said. At this point, Metro Nashville Police said they are connecting three, different shootings with four victims – three of whom have died. The police department tweeted Monday morning that Chief Steve Anderson met with detectives in the case and said strong leads are being pursued. The first incident happened back on Aug. 8 in the Inglewood area when a 39-year-old woman was shot while walking her dog just before 1 a.m. She survived but police have confirmed the shooting left her paralyzed.Less than a week later, investigators said 31-year-old Kendall Rice was walking to work when he was robbed and fatally shot on Alta Loma Road in Madison. Kendall RiceThe third shooting linked to the spree happened around 3:30 a.m. Friday in East Nashville outside of The Cobra Nashville, a local bar.  Four people were heading to get a snack at a convenience store when they were robbed. Police said 33-year-old Bartley Teal and 30-year-old Jaime Sarrantonio were shot and killed. Jaime Sarrantonio and Bartley TealEarlier in the week, police officials said the three crimes and possibly two more could be linked but narrowed it down to the three shootings on Friday. 1361

(CNN) -- Another mountaineer has died after summiting Mount Everest, bringing the death toll for the 2019 climbing season to 11 people.American Christopher John Kulish, 61, died on Monday after reaching the top of Everest on the Nepalese side of the mountain in the morning, Meera Acharya, the Director of Nepal's Tourism Department told CNN.While descending, he was strong and safely reached the South Col (situated at an altitude of around 7,900 meters, or 25,918 feet) late Monday evening before he suddenly passed away, she said.Also on Monday, an Austrian family confirmed the death of one of their relatives. Sixty-four-year-old Ernst Landgraf died on Thursday, hours after fulfilling his dream of scaling Everest, according to his obituary and funeral announcement placed by his family.Landgraf lived for his family, climbing, and died fulfilling his dream, the obituary read in part. He is survived by his wife and children. His memorial service will be Wednesday in Ubelbach, Austria.Mountaineers have suggested difficult weather conditions, a lack of experience and the growing commercialization of expeditions as contributing factors to the backlog.British climber Robin Haynes Fisher was one of those who had warned of the dangers of overcrowding."With a single route to the summit, delays caused by overcrowding could prove fatal so I am hopeful my decision to go for the 25th will mean fewer people. Unless of course everyone else plays the same waiting game," he wrote in a captioned Instagram post on May 19.He died after suffering from what appeared to be altitude sickness at 8,600 meters (28,215 feet), while returning from the summit on Saturday.During the week beginning May 20, crowds of climbers became stuck in a queue to the summit, above the mountain's highest camp at 8,000 meters (26,247 feet). The summit of Mount Everest is 8,848 meters (29,029 feet) high.Most people can only spend a matter of minutes at the summit without extra oxygen supplies, and the area where mountaineers have been delayed is known to many as the "death zone."Mountain guide Adrian Ballinger told CNN many see Everest as the "ultimate challenge" but the problem he has seen is the "lower level of experience of the climbers trying to come here and also of the companies that are trying to offer services on the mountain."He continued, "That lack of experience, both with the commercial operators and the climbers themselves, is causing these images we see where people make bad decisions, get themselves in trouble up high and end up having unnecessary fatalities."Ballinger explained that seasoned climbers call any part of the mountain above 26,000 feet "the death zone," adding that "humans just really aren't meant to exist there.""Even when using bottled oxygen, supplemental oxygen, there's only a very few number of hours that we can actually survive up there before our bodies start to shut down. So that means if you get caught in a traffic jam above 26,000 feet ... the consequences can be really severe," he added.Nepali climbing guide Dhruba Bista fell ill on the mountain and was transported by helicopter to the base camp, where he died Friday.And Irish climber Kevin Hynes, 56, died Friday morning on the Tibetan side of Everest in his tent at 7,000 meters (22,966 feet).Two died Wednesday after descending from the summit: Indian climber Anjali Kulkarni, 55, and American climber Donald Lynn Cash, 55.Kalpana Das, 49, and Nihal Bagwan, 27, both from India, also died on Everest this week. Both died Thursday on their return from the summit.Ravi, a 28-year-old Indian climber who goes by one name, died the previous week on May 17.Last week, a search for Irish climber Seamus Lawless, 39, was called off, after the Trinity College Dublin professor fell while descending from the peak, according to the Press Assocation.Lawless is missing, presumed dead.More than 200 mountaineers have died on the peak since 1922, when the first climbers' deaths on Everest were recorded. The majority of bodies are believed to have remained buried under glaciers or snow. 4083

(AP) - With CBD showing up everywhere, U.S. regulators announced Tuesday they are exploring ways the marijuana extract could be used legally in foods, dietary supplements and cosmetics.The U.S. Food and Drug Administration said it will hold a public hearing May 31 to gather more information on the science, manufacturing and sale of cannabis compounds like CBD.In the meantime, it issued more warning letters to companies for making unapproved health claims about CBD products.Products containing CBD are already in stores and sold online, so it's easy to believe there must be something special about the ingredient. But the claims are largely unproven and quality control standards don't exist.RELATED: Can using CBD products cost someone their job? A look at what we know as U.S. regulators work out what will and won't be allowed:WHAT IS CBD?CBD is one of more than 100 compounds found in marijuana. It's extracted using alcohol or carbon dioxide in factories. It's added to oils, mixed into creams and lotions and sold in candies and liquid drops.Widely sold online, CBD now is going mainstream with major retailers offering salves and balms for the skin. Prices range from to 0 an ounce at high-end shops.CBD often comes from a cannabis plant known as hemp, which is defined by the U.S. government as having less than 0.3 percent THC. That's important because THC is what causes marijuana's mind-altering effect.CBD doesn't get people high, although it may be calming. Keep in mind some CBD products may contain THC, whether or not the label says so.RELATED: CBD-infused foods become rising trend in 2019People drug tested for work, addiction programs or because they take prescription opioids should take note: CBD products have caused people to fail urine drug screens.IS IT A MIRACLE CURE?If you believe the hype, CBD treats pain, relieves anxiety and both helps you sleep and keeps you focused.Most claims are based on studies in rats, mice or in test tubes. Some human research has been done, but in small numbers of people.One exception: For two rare seizure disorders, the evidence for CBD was strong enough to convince the FDA to approve GW Pharmaceutical's drug Epidiolex, which contains a purified form.The FDA announced Tuesday it has sent warning letters to three companies marketing products with what outgoing Commissioner Scott Gottlieb called "egregious, over-the-line claims" for CBD's effects on cancer, Alzheimer's disease, fibromyalgia and drug addiction. Gottlieb said the agency "won't tolerate this kind of deceptive marketing to vulnerable patients."RELATED: CVS Pharmacy selling cannabis-based products in stores in California, 7 other statesOnly drugs that have been reviewed by the FDA as safe and effective can make claims that they treat or prevent diseases or medical conditions. Many CBD producers attempt to sidestep the issue by using only vague language about general health and well-being.ANY SIDE EFFECTS?Scant research means not much is known about side effects either. In epilepsy research, CBD changed the way the body processed other drugs. That suggests CBD could interact with medications in ways we still don't know about.The most common side effects of the CBD drug Epidiolex include sleepiness, decreased appetite, diarrhea, increases in liver enzymes, exhaustion, rash and infections. FDA's Gottlieb noted Tuesday the potential for liver injury and other risks can be handled with medical supervision but less is known about how that would be managed without oversight. And there are questions about overlap if multiple CBD products are used.IS IT LEGAL?For now, the agency has said CBD is not allowed as an ingredient in food, drinks or dietary supplements.In stating its position, the FDA cited a provision of the law prohibiting food makers from using active drug ingredients or those that are the subject of substantial research. But the agency doesn't have the resources to police all the CBD products that are already available, said Marc Scheineson, a former FDA official.RELATED: Creator of Jelly Belly releases CBD-infused jelly beans"They're not going to pull a thousand products from the market," he said.The FDA's authority is over interstate commerce, and local officials have taken differing approaches. In New York, Los Angeles and elsewhere, officials are warning eateries to stop selling it in food and drinks. Maine passed a law allowing it in foods and other products in the state.Skin creams and cosmetics may be on safer footing with the FDA, but that too remains uncertain, said Camille Gourdet of RTI International, a nonprofit research institute in Durham, North Carolina. Though cosmetics aren't subject to premarket approval by the FDA, they could run afoul of regulations if they make specific health claims.Marijuana itself is illegal under federal law; most states that have legalized it allow marijuana-infused foods and candies, called edibles.ARE CBD LABELS ACCURATE?What you buy may contain much less CBD than the label states — or much more. It may include more THC than you want and it may be contaminated with mold or pesticides. Ask to see testing reports.A 2017 study in the Journal of the American Medical Association found 70 percent of CBD products were mislabeled. Researchers used an independent lab to test 84 products from 31 companies."You're really flying by the seat of your pants when you buy this stuff," said author Marcel Bonn-Miller of University of Pennsylvania.A product labeled as containing 100 milligrams of CBD may only have 5 milligrams or it may have 200, said Bonn-Miller, now an adviser for a company that sells CBD and other cannabis products. He did not work in the industry when he did the research."I wouldn't trust any of it until I knew independently it was safe," Bonn-Miller said.WHAT'S AHEAD?CBD research is planned or underway for cancer, autism, diabetic neuropathy, fibromyalgia, chronic pain, alcoholism with PTSD and psychiatric conditions. Results will take years, but some people aren't waiting."They are vulnerable and really hoping to feel better," said Karen Hande, a nurse practitioner at Vanderbilt-Ingram Cancer Center in Nashville.She became an expert in CBD because so many of her cancer patients were trying it. She tells them the evidence isn't enough to back the claims, but "they want to believe something is going to work." 6383